Nitrofurazone and Systemic lupus erythematosus - a phase IV clinical study of FDA data
Summary:
Systemic lupus erythematosus is reported as a side effect among people who take Nitrofurazone (nitrofurazone), especially for people who are female, 40-49 old, also take Morphine Sulfate, and have Psoriatic arthropathy.
The phase IV clinical study analyzes which people have Systemic lupus erythematosus when taking Nitrofurazone. It is created by eHealthMe based on reports of 89 people who have side effects when taking Nitrofurazone from the FDA, and is updated regularly.
What is Nitrofurazone?
Nitrofurazone has active ingredients of nitrofurazone. eHealthMe is studying from 95 Nitrofurazone users. Check the latest studies of Nitrofurazone.
What is Systemic lupus erythematosus?
Systemic lupus erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue) is found to be associated with 1,088 drugs and 1,643 conditions by eHealthMe. Check the latest studies of Systemic lupus erythematosus.
89 people reported to have side effects when taking Nitrofurazone.
Among them, 14 people (15.73%) have Systemic lupus erythematosus.

Among these 14 people:
What is the gender of people who have Systemic lupus erythematosus when taking Nitrofurazone? *
- female: 100 %
- male: 0.0 %
What is the age of people who have Systemic lupus erythematosus when taking Nitrofurazone? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 66.67 %
- 50-59: 33.33 %
- 60+: 0.0 %
What are other drugs people take besides Nitrofurazone? *
- Acetaminophen: 14 people, 100.00%
- Sulfasalazine: 14 people, 100.00%
- Cimzia: 14 people, 100.00%
- Desoximetasone: 14 people, 100.00%
- Calcium Carbonate: 14 people, 100.00%
- Enbrel: 14 people, 100.00%
- Folic Acid: 14 people, 100.00%
- Humira: 14 people, 100.00%
- Lyrica: 14 people, 100.00%
- Morphine Sulfate: 14 people, 100.00%
What are other side effects people have besides Systemic lupus erythematosus? *
- Swelling: 13 people, 92.86%
- Synovitis (inflammation of the synovial membrane): 13 people, 92.86%
- Infusion Related Reaction: 13 people, 92.86%
- Indigestion: 13 people, 92.86%
- Joint Swelling: 13 people, 92.86%
- High Blood Pressure: 13 people, 92.86%
- High Blood Cholesterol: 13 people, 92.86%
- Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 13 people, 92.86%
- Duodenal Ulcer Perforation (untreated ulcer can burn through the wall of the stomach): 13 people, 92.86%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 13 people, 92.86%
What are the existing conditions these people have? *
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 8 people, 57.14%
- Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 8 people, 57.14%
- Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 7 people, 50.00%
- Fibromyalgia (a long-term condition which causes pain all over the body): 4 people, 28.57%
- Psoriasis (immune-mediated disease that affects the skin): 3 people, 21.43%
- Indigestion: 3 people, 21.43%
- Headache (pain in head): 3 people, 21.43%
- Pain: 2 people, 14.29%
- Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 1 person, 7.14%
- Ankylosing Spondylitis (type of arthritis affecting the spine): 1 person, 7.14%
* Approximation only. Some reports may have incomplete information.
Do you take Nitrofurazone and have Systemic lupus erythematosus?
- Check whether Systemic lupus erythematosus is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Nitrofurazone:
- Nitrofurazone (95 reports)
Systemic lupus erythematosus treatments and more:
- Systemic lupus erythematosus (76,947 reports)
How severe was Systemic lupus erythematosus and when was it recovered:
Expand to all the drugs that have ingredients of nitrofurazone:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Nitrofurazone:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Systemic lupus erythematosus:
- Systemic lupus erythematosus (1,088 drugs)
Browse all the conditions that are associated with Systemic lupus erythematosus:
- Systemic lupus erythematosus (1,643 conditions)
Related publications that referenced our studies
- Hania A, "Pyoderma Gangrenosum in a Patient With Systemic Lupus Erythematosus: Case Report", Journal of Medical Cases, 2014 Aug .
- Hu P, Lu L, Hu B, Deng F, Fei WJ, "Cyclophosphamide‐Induced Hypertensive Encephalopathy in a Young Girl With Lupus", The Journal of Clinical Hypertension, 2012 Apr .
- Hania A, "Pyoderma Gangrenosum in a Patient With Systemic Lupus Erythematosus: Case Report", Journal of Medical Cases, 2014 Aug .
- Hu P, Lu L, Hu B, Deng F, Fei WJ, "Cyclophosphamide‐Induced Hypertensive Encephalopathy in a Young Girl With Lupus", The Journal of Clinical Hypertension, 2012 Apr .
How the study uses the data?
The study uses data from the FDA. It is based on nitrofurazone (the active ingredients of Nitrofurazone) and Nitrofurazone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Solu-Medrol cause Joint Injury? - 25 seconds ago
- Could Neupogen cause Sleep Apnea Syndrome? - 37 seconds ago
- Arterial Disorder and Joint Pain - 50 seconds ago
- Drug interactions of Mirabegron and Tacrolimus - 59 seconds ago
- Could Dexmedetomidine Hydrochloride cause Weakness? - 59 seconds ago
- Klonopin Rapidly Disintegrating vs. Pristiq, side effect and effectiveness comparison - a minute ago
- Appetite Disorder and Joint Pain - a minute ago
- Drug interactions of Fentanyl Citrate and Zovirax - a minute ago
- Could Paracetamol cause Cardiac Arrest? - a minute ago
- Could Dimenhydrinate cause Escherichia Bacteraemia? - a minute ago